[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Liang et al., 2016 - Google Patents

Facile assembly of functional upconversion nanoparticles for targeted cancer imaging and photodynamic therapy

Liang et al., 2016

View PDF
Document ID
16251517128391064052
Author
Liang L
Care A
Zhang R
Lu Y
Packer N
Sunna A
Qian Y
Zvyagin A
Publication year
Publication venue
ACS applied materials & interfaces

External Links

Snippet

The treatment depth of existing photodynamic therapy (PDT) is limited because of the absorption of visible excitation light in biological tissue. It can be augmented by means of upconversion nanoparticles (UCNPs) transforming deep-penetrating near-infrared (NIR) …
Continue reading at pstorage-acs-6854636.s3.amazonaws.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds

Similar Documents

Publication Publication Date Title
Liang et al. Facile assembly of functional upconversion nanoparticles for targeted cancer imaging and photodynamic therapy
Tang et al. Near-infrared excited orthogonal emissive upconversion nanoparticles for imaging-guided on-demand therapy
Chen et al. Aza-BODIPY-based nanomedicines in cancer phototheranostics
Hsu et al. Lanthanide-doped core–shell–shell nanocomposite for dual photodynamic therapy and luminescence imaging by a single X-ray excitation source
Xu et al. Highly emissive dye-sensitized upconversion nanostructure for dual-photosensitizer photodynamic therapy and bioimaging
Lv et al. In situ growth strategy to integrate up-conversion nanoparticles with ultrasmall CuS for photothermal theranostics
Sun et al. Honeycomb-satellite structured pH/H2O2-responsive degradable nanoplatform for efficient photodynamic therapy and multimodal imaging
Cao et al. Engineered exosome-mediated near-infrared-II region V2C quantum dot delivery for nucleus-target low-temperature photothermal therapy
Sabri et al. Dual activity of rose bengal functionalized to albumin-coated lanthanide-doped upconverting nanoparticles: targeting and photodynamic therapy
Peng et al. Multifunctional nanosystem for synergistic tumor therapy delivered by two-dimensional MoS2
Liu et al. Ultrasmall WO3–x@ γ-poly-l-glutamic acid nanoparticles as a photoacoustic imaging and effective photothermal-enhanced chemodynamic therapy agent for cancer
Sun et al. Photothermal fenton nanocatalysts for synergetic cancer therapy in the second near-infrared window
Chen et al. Plasmon-enhanced photodynamic cancer therapy by upconversion nanoparticles conjugated with Au nanorods
Nair et al. Fluorescence imaging assisted photodynamic therapy using photosensitizer-linked gold quantum clusters
Liu et al. Amplified photoacoustic signal and enhanced photothermal conversion of polydopamine-coated gold nanobipyramids for phototheranostics and synergistic chemotherapy
Han et al. An extendable star-like nanoplatform for functional and anatomical imaging-guided photothermal oncotherapy
Liu et al. Covalently assembled NIR nanoplatform for simultaneous fluorescence imaging and photodynamic therapy of cancer cells
Yang et al. A single 808 nm near-infrared light-mediated multiple imaging and photodynamic therapy based on titania coupled upconversion nanoparticles
Liu et al. Silica coated upconversion nanoparticles: a versatile platform for the development of efficient theranostics
Wang et al. Design and synthesis of core–shell–shell upconversion nanoparticles for NIR-induced drug release, photodynamic therapy, and cell imaging
Yen et al. Design and synthesis of polymer-functionalized NIR fluorescent dyes–magnetic nanoparticles for bioimaging
Yu et al. A near-infrared triggered nanophotosensitizer inducing domino effect on mitochondrial reactive oxygen species burst for cancer therapy
Lin et al. Facial layer-by-layer engineering of upconversion nanoparticles for gene delivery: near-infrared-initiated fluorescence resonance energy transfer tracking and overcoming drug resistance in ovarian cancer
Zhao et al. Nanocomposites containing gold nanorods and porphyrin-doped mesoporous silica with dual capability of two-photon imaging and photosensitization
Cheng et al. Upconversion nanoparticles and their composite nanostructures for biomedical imaging and cancer therapy